![]() |
|
|
Vol. 289, Issue 2, 1104-1111, May 1999
Department of Pharmacology, Faculty of Medical Sciences, University of Nijmegen, Nijmegen, the Netherlands (R.M., M.M.M., F.G.M.R.); and Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina (B.H.T., D.S.M.)
| |
Abstract |
|---|
|
|
|---|
Recent studies show that organic anion secretion in renal proximal tubule is mediated by distinct sodium-dependent and sodium-independent transport systems. Here we investigated the possibility that organic anions entering the cells on one system can exit into the lumen on a transporter associated with the other system. In isolated rat kidneys perfused with 10 µM lucifer yellow (LY, a fluorescent organic anion) plus 100 µg/ml inulin, the LY-to-inulin clearance ratio averaged 1.6 ± 0.2, indicating net tubular secretion. Probenecid significantly reduced both LY clearance and LY accumulation in kidney tissue. In intact killifish proximal tubules, confocal microscopy was used to measure steady-state LY uptake into cells and secretion into the tubular lumen. Probenecid, p-aminohippurate, and ouabain nearly abolished both uptake and secretion. To this point, the data indicated that LY was handled by the sodium-dependent and ouabain-sensitive organic anion transport system. However, leukotriene C4, an inhibitor of the luminal step for the sodium-independent and ouabain-insensitive organic anion system, reduced luminal secretion of LY by 50%. Leukotriene C4 did not affect cellular accumulation of LY or the transport of fluorescein on the sodium-dependent system. A similar inhibition pattern was found for another fluorescent organic anion, a mercapturic acid derivative of monochlorobimane. Thus, both organic anions entered the cells on the basolateral transporter for the classical, sodium-dependent system, but about half of the transport into the lumen was handled by the luminal carrier for the sodium-independent system, which is most likely the multidrug resistance-associated protein. This is the first demonstration that xenobiotics can enter renal proximal tubule cells on the carrier associated with one organic anion transport system and exit into the tubular lumen on multiple carriers, one of which is associated with a second system.
| |
Introduction |
|---|
|
|
|---|
Organisms
use two general strategies to modify the biological activity of
potentially toxic xenobiotics: altering chemical reactivity through
metabolism and removing biologically active molecules and their
metabolites from sensitive sites by excretory transport. A major
function of renal proximal tubule is the transport from blood to urine
of a wide variety of potentially toxic metabolic wastes, drugs,
pollutants, and drug and pollutant metabolites. Anionic xenobiotics are
handled by a long-studied, classical, sodium-dependent system
(Pritchard and Miller, 1993
, 1996
) and by a newly discovered,
sodium-independent system (Masereeuw et al., 1996b
). These systems are
similar in that both involve two transport steps arranged in series:
the first at the basolateral membrane of renal epithelial cells and a
second at the luminal membrane. Substrates for both systems also
accumulate in intracellular compartments (Miller et al., 1993
;
Masereeuw et al., 1994
, 1996b
). The systems differ in the specificities
and energetics of the carriers involved (Fig.
1). Renal secretion on the classical
system is driven by indirect coupling of organic anion influx to sodium at the basolateral membrane followed by carrier-mediated transport at
the luminal membrane. Secretion on the sodium-independent system is
driven by an as yet uncharacterized carrier at the basolateral membrane
followed by cell-to-lumen transport on a carrier with specificity
characteristics similar to that of a xenobiotic-transporting ATPase (a
multidrug resistance-associated protein isoform, Mrp2). This transport
protein has been localized to the canalicular membrane of hepatocytes
(Paulusma et al., 1996
) and the luminal membrane of rat renal proximal
tubule cells (Schaub et al., 1997
).
|
Masereeuw et al. (unpublished data) not only demonstrated the presence
of Mrp2 in killifish renal proximal tubules, but also provided
experimental criteria by which the route of secretion from bath to
tubular lumen could be determined for fluorescent substrates (Masereeuw
et al., 1996b
). The defining criteria were sodium dependence and
ouabain sensitivity at the basolateral membrane and leukotriene
C4 (LTC4) and cyclosporin A
sensitivity at the luminal membrane. By these criteria, the small
organic anion, fluorescein (FL), crossed the epithelium using carriers
associated with the sodium-dependent system, because uptake by cells
and secretion into the lumen were abolished by ouabain but
LTC4 was without effect. In contrast, the large
organic anion, fluorescein methotrexate (FL-MTX), entered the cells on
the basolateral carrier for the sodium-independent system (lack of
inhibition by ouabain) and was transported into the lumen primarily on
Mrp2 (inhibition by LTC4). Sulforhodamine 101, intermediate in size, exhibited intermediate sensitivities to ouabain
and LTC4, indicating partitioning of transport
between the two systems. These results imply that one could simply
consider selectivity as a function of transport system rather than as a
function of the individual carriers involved, i.e., the transport
systems could be treated as if they were competing metabolic pathways.
In the present study, we tested this inference by examining the
transport of the fluorescent organic anion, lucifer yellow (LY). This
dye has been used extensively in cell biology as a tool to trace cell
lineage and to investigate gap junction function. Little is known about
the mechanisms of LY transport. It is clear that macrophages possess a
potent mechanism for LY efflux, and, based on the probenecid
sensitivity of that process, it was proposed that a transport system
comparable to the organic anion secretory system in renal proximal
tubule mediates LY efflux (Steinberg et al., 1987
). However, no
evidence for specific transport of LY was found in monolayers of canine
proximal tubular cells in primary culture, although these monolayers
did exhibit a net reabsorptive paracellular flux of LY (Goligorsky and
Hruska, 1986
). Here, we used fluorometry and confocal microscopy to
examine the renal handling of LY. Our results indicate that: 1) LY
undergoes net secretion by the isolated perfused rat kidney (IPK), 2)
LY is secreted in killifish renal proximal tubules by a process that is
inhibited by small organic anions and nearly abolished by ouabain, but
3) a substantial fraction of the transport of LY from cell to tubular
lumen is blocked by LTC4. A similar inhibition
pattern also was found for a fluorescent mercapturic acid derivative. Together, the data indicate that these organic anions enter renal proximal tubule cells on the sodium-dependent organic anion system, but
that a substantial component of transport from cell to lumen is on the
carrier for the sodium-independent system Mrp2.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Sodium pentobarbital was obtained from Apharmo
(Arnhem, the Netherlands), pluronic F-108 was obtained from BASF
(Arnhem, the Netherlands), and heparin, aldosterone, and inulin were
obtained from Organon (Oss, the Netherlands). LY-CH dilithium
salt, leukotriene C4, and chlorodinitrobenzene
were purchased from Sigma (St. Louis, MO). Lysine-vasopressin was
obtained from Sandoz Pharma Ltd. (Basel, Switzerland), angiotensin II
was obtained from Beckman (Palo Alto, CA), and synthamin 14 was
obtained from Travenol (Thetford, Norfolk, UK). The mercapturic acid
derivative of monochlorobimane (MCB) was synthesized by reacting MCB
(Molecular Probes) with an excess of N-acetylcysteine; the
derivative was purified by HPLC as described previously (Miller et al.,
1996
). All other chemicals were purchased from either Sigma or Merck
(Darmstadt, Germany) and were of analytical grade.
Kidney Isolation and Perfusion.
Rat kidneys were isolated
and perfused as described in detail previously (Cox et al., 1990
).
Briefly, male Wistar-Hannover rats (225-275 g) were anesthetized i.p.
with pentobarbital (6 mg/100 g) and furosemide was injected i.p. (1 mg/100 g) to prevent deterioration of the distal nephron. Heparin (125 I.U./100 g) was injected in the femoral vein. The ureter of the right
kidney was cannulated as well as the renal artery via the mesenteric artery without interruption of the blood flow. The kidney then was excised and placed in a fluid bath with a constant temperature of
37.5°C. The perfusate reservoir also was placed in a water bath of
37.5°C, and fluid was gassed with 95% O2/5%
CO2. The perfusion fluid had the following
composition: 114.0 mM NaCl, 5.2 mM KCl, 1.8 mM
CaCl2, 1.0 mM MgCl2, 22.5 mM NaHCO3, 0.84 mM
Na2HPO4, 0.28 mM
KH2PO4, 5.0 mM glucose, 4.0 mM urea, 25.0 g/liter pluronic F108, 0.33 mM glutathione, 0.083 mM
inositol, 0.50 mM cysteine, 2.3 mM glycine, 2.0 mM sodium-pyruvate,
1.22 mM sodium-acetate, 0.21 mM sodium-propionate, 1.0 mM inosine, 5.0 mM alanine, 0.11 mM glutamine, 2.0 mM L-glutamine acid,
0.01 mM ascorbic acid, 1.0 mM sodium-lactate, 1.0 mg/liter choline
chloride, 4 I.U./liter insulin, 2.0 µg/liter aldosterone, 0.01 I.U./liter lysine-vasopressin, and 15.0 ng/liter angiotensin II. To
this solution 1.0% synthamin 14, a mixture of 15 amino acids, was
added. Pluronic F-108 was used as oncotic agent in the albumin-free
perfusion fluid. For the determination of glomerular filtration rate
(GFR), inulin was added to the perfusion fluid (100 µg/ml).
-ketoglutarate (1.15 mM)
and probenecid (0.5 mM) on LY clearance were studied, these agents were
added to the perfused rat kidney at the start of the baseline period
and remained in the perfusion fluid during the entire experimental
period. Urine samples were collected during control and experimental
periods over 10-min intervals. Perfusate samples (300 µl) were drawn
at the midpoint of each urine-collection interval. Two additional
perfusate samples were taken: one at the beginning of the experimental
period (t = 0), and one at the end of the experiment.
At the end of the experiment the kidney was removed from the system,
blotted, weighed, and frozen until analysis. Urine and perfusate
samples were stored at
20°C until analysis. Perfusion fluid during
the experimental period as well as perfusion and urine samples were
protected from light.
Analytical Methods.
Inulin was determined according to a
previously published method (Heyrovski, 1956
). The concentration of LY
in perfusate, urine, and kidney samples was determined by fluorescence
spectrophotometry. To this end, an aliquot of 50 µl of the perfusate
sample was taken and adjusted to 600 µl with analysis buffer
(Sörensen buffer, pH 7.36). Urine samples were diluted 10 times
with buffer, from which an aliquot of 25 µl was taken and adjusted to
600 µl with 50 µl of blank perfusion fluid and 525 µl buffer.
Fluorescence in these prepared samples was measured using a
Perkin-Elmer LS50 luminescence spectrophotometer (Perkin-Elmer Ltd.,
Beaconsfield, Buckinghamshire, UK). The excitation wavelength was set
to 425 nm, the emission wavelength was set to 525 nm, and, for both
wavelengths, a band width of 5 nm was used. Concentrations were
calculated by comparing fluorescence intensity (in photomultiplier
units) with a calibration curve of spiked samples of blank perfusion fluid with different concentrations of LY. The concentration of LY in
kidney tissue extracts was determined similarly. The kidneys were
homogenized in 2.5 ml of distilled water with a Polytron homogenizer
(Braun Melsungen, Germany) on setting 10 for 2 × 60 s.
Subsequently, 100 µl of 6 N HCl was added to 500 µl of the kidney
homogenate, vortexed, and centrifuged for 10 min at 2000g. Of the supernatant, an aliquot of 100 µl was taken and adjusted to
600 µl with buffer, and fluorescence intensities of quadruplicate samples were measured and averaged. Concentrations were calculated by
comparing fluorescence intensity with a calibration curve of spiked
samples of blank kidney homogenates with various concentrations of LY.
Killifish Proximal Tubule Isolation.
Killifish
(Fundulus heteroclitus) were collected near Duke University
Marine Laboratory (Beaufort, NC) and maintained in tanks with
recirculating, artificial sea water (18°C) at the National Institute
of Environmental Health Sciences. Killifish proximal tubules were
isolated by dissection of renal tubular masses with forceps, as
described previously (Miller and Pritchard, 1991
, 1994
; Masereeuw et
al., 1996b
). Proximal tubules were maintained in a marine teleost
saline based on that of Forster and Taggart (1950)
, containing 140 mM
NaCl, 2.5 mM KCl, 1.5 mM CaCl2, 1.0 mM
MgCl2, and 20 mM Tris, pH 8.0.
Confocal Microscopy. For microscopy, killifish proximal tubules were transferred to a Teflon chamber (Bionique) with a 4 × 4-cm glass coverslip floor containing 1.5 ml of marine teleost saline. Killifish proximal tubules were preincubated for 15 min (18°C) in the absence (controls) and presence of various inhibitors under an atmosphere of 95% oxygen and 5% carbon dioxide. Then, LY (final concentration of 2 µM) was added to the tubules and incubation took place for 30 min at room temperature.
Confocal fluorescent images were obtained with a Zeiss LSM 410 confocal microscope (Carl Zeiss, Oberkochen, Germany). The system consisted of an inverted microscope, a mixed argon/krypton-ion laser with the 488- and 568-nm lines, and an argon ion laser for ultraviolet (364 nm) excitation. For measurement of LY and fluorescein, the 488-nm laser line, a 510-nm dichroic filter, and a 515-nm long-pass emission filter were employed. For measurement of the MCB metabolite, the 364-nm laser line, a 395-nm dichroic filter, and a 460- to 510-nm band-pass emission filter were employed. The microscope was equipped with a 40× oil-immersion objective, exhibiting a numerical aperture of 1.3. The software used to obtain the images was Zeiss LSM4 (Carl Zeiss). Unless indicated otherwise, images were collected with a zoom setting of 2 (0.313 µm/pixel). Neutral density filters passing 10% of the light and a laser power of 20% were used to minimize photobleaching. To obtain an image, dye-loaded cells or tubules in the chamber were viewed under reduced, transmitted light illumination, and a field containing 20 to 30 cells or 1 to 3 tubules was selected. Then, in confocal fluorescence mode, a single 8-s scan of the field was collected. The confocal image (512 × 512 × 8 bits) was viewed on a high-resolution monitor and stored on an optical disk. Fluorescence intensities were analyzed using a Macintosh computer equipped with image analysis software (Image 1.54; National Institutes of Health) as described previously (Miller, 1995Data Analysis. Data of isolated perfused kidney are expressed as mean ± S.D. All other data are expressed as mean ± S.E., unless indicated otherwise. Student's t test was used to evaluate statistical significance in the renal clearance studies. Statistical differences between multiple means were determined with one-way ANOVA followed by the least significant difference post test. Means were considered significantly different when P < .05.
| |
Results |
|---|
|
|
|---|
Transport of LY in the Isolated Perfused Rat Kidney.
The
viability of perfused rat kidneys was assessed by following fractional
excretion of sodium and glucose, fractional reabsorption of water,
urine flow and pH, GFR, and renal perfusate pressure. Based on these
criteria, kidneys showed excellent transport function over the 2-h time
course of the LY clearance experiments (Table 1). Pretreating kidneys with probenecid
or
-ketoglutarate did not alter kidney function.
|
-ketoglutarate to the
perfusate significantly reduced the clearance ratio (Fig. 2). For
example, from 60 to 120 min, mean clearance ratios were reduced 52 ± 3% by probenecid and 32 ± 4% by
-ketoglutarate.
Furthermore, probenecid reduced the clearance ratio to a value that was
significantly lower than unity (P < .05; Fig. 2),
indicating net reabsorption of LY. These reductions in clearance ratio
were solely the result of decreased LY clearance, because neither
probenecid nor
-ketoglutarate affected inulin clearance (Table 1).
|
-ketoglutarate also reduced total LY accumulation in
kidney tissue. After each perfusion experiment, we measured tissue LY
content and kidney weight and calculated an accumulation ratio by
dividing µmol/g LY by the concentration in the perfusate. In control
kidneys, the tissue-to-perfusate ratio averaged 2.0 ± 0.2, a
value that is significantly higher than unity (P < .01). Probenecid and
-ketoglutarate reduced this ratio by 62 ± 6% and 37 ± 7%, respectively; with probenecid, the LY
accumulation ratio did not exceed unity. Together, the clearance and
tissue uptake data from the perfused rat kidney experiments indicate
that LY was both actively secreted into urine and accumulated within
kidney tissue, as was observed for other organic anions in previous
studies with perfused rat kidneys (Masereeuw et al., 1996a
-ketoglutarate, indicating the participation of an
organic anion transport system in the renal handling of LY.
LY Uptake and Secretion by Killifish Renal Proximal Tubules.
Isolated renal proximal tubules from certain marine teleost fish offer
several advantages for the study of mechanisms of xenobiotic secretion
(Miller and Pritchard, 1991
). The nephron of these animals is composed
primarily of proximal tubules, which are isolated easily and retain
viability for long periods of time when maintained in a simple
physiological saline. During tubule isolation, broken ends reseal and
form a closed, fluid-filled luminal compartment that is separated from
the medium by the epithelium. Finally, using fluorescent substrates,
confocal microscopy and image analysis xenobiotic uptake by cells and
secretion into the lumen can be visualized and measured (Miller and
Pritchard, 1994
; Masereeuw et al., 1996b
; Miller et al., 1996
).
|
|
|
|
|
|
Transport of a Bimane Mercapturic Acid Derivative.
MCB is a
nonfluorescent, uncharged compound that enters cells by simple
diffusion and is conjugated to GSH by GSH-transferase. The GSH
derivative of MCB and all bimane-S metabolites are negatively charged and fluorescent. MCB has been used as a tool to study organic
anion transport mechanisms in hepatocytes and renal proximal tubules.
The mercapturic acid derivative of MCB (MCB-cys-Nac) is the final
product of the renal metabolism of the GSH-conjugate of MCB. Like other
sulfur-linked conjugates of MCB, MCB-cys-Nac is anionic and
fluorescent. Previous experiments have shown that the mercapturic acid
derivative of MCB is formed when isolated killifish renal tubules are
exposed to MCB and that this derivative inhibits the uptake and
secretion of FL (Miller et al., 1996
).
|
|
| |
Discussion |
|---|
|
|
|---|
By mediating active drug excretion, xenobiotic transporters play a major role in determining drug concentrations reaching sensitive sites within an organism. Along with drug metabolizing enzymes, these transporters are important determinants of drug effectiveness on the one hand and of xenobiotic toxicity on the other. Moreover, because of their wide specificity limits, these transporters also provide a mechanism, competition for transport, by which chemicals with very different structures may interact to alter xenobiotic-excretion rates, plasma-concentration profiles, and tissue-distribution patterns. Thus, it is important to characterize the individual transporters that drive excretion, understand how xenobiotics interact with these membrane proteins, and identify the routes that chemicals follow during transport from blood to urine.
The results of the present study provide the first evidence for active
secretion of LY in renal proximal tubule. This conclusion is supported
by two types of experiments. First, in isolated perfused rat kidney, LY
clearance exceeded the GFR by a factor of nearly 2. LY clearance, but
not GFR, was reduced significantly by the organic anions, probenecid
and
-ketoglutarate. LY accumulation in kidney tissue was reduced
similarly by probenecid and
-ketoglutarate. Second, in isolated
killifish renal proximal tubules, confocal microscopy showed that LY
was transported from bath to tubular lumen by a process that was
concentrative and sensitive to inhibition by probenecid and PAH and by
the Na,K-ATPase inhibitor, ouabain. At present, it is not clear why
specific LY transport was not seen in a previous study with monolayers
of canine proximal tubular cells (Goligorsky and Hruska, 1986
), but
species differences or differences in the transport characteristics of
cells in culture versus cells in an intact tubule are possible explanations.
Based on the ability of organic anions, such as PAH and probenecid, to
inhibit LY cellular accumulation in rat renal tissue and killifish
proximal tubule cells and to inhibit LY secretion in perfused rat
kidneys and killifish proximal tubules, LY transport appeared to be
mediated by a renal organic anion system. Two such transport systems
have been identified. The classical organic anion transport system,
which appears to be present in the renal systems of all animals studied
(Pritchard and Miller, 1993
), is sodium-dependent and
ouabain-sensitive. The system for large organic anions is
sodium-independent and ouabain-insensitive. It was first demonstrated
in killifish proximal tubules (Masereeuw et al., 1996b
; unpublished
data), but at least one component of that system, the luminal carrier
(Mrp2), also has been shown to be present in rat proximal tubule
(Schaub et al., 1997
).
Each system appears to use different transporters at the basolateral
and luminal membranes (Fig. 1). Thus, at least four transporters can be
involved in organic anion secretion. For fluorescent substrates, these
can be sorted out in killifish tubules by simple inhibition experiments
using ouabain and LTC4 (Fig. 1). The present data show that LY entered proximal tubule cells on the sodium-dependent basolateral carrier for small organic anions, because LY uptake and
secretion, like FL, were nearly abolished by ouabain. LY was transported into the tubular lumen by the luminal transporters for both
systems, because LTC4 reduced secretion by about
50% and because, with 200 to 300 nM LTC4,
luminal fluorescence still exceeded cellular fluorescence by a factor
of 2 to 3. We assume that the LTC4-insensitive
component of secretion was on the luminal carrier for small organic
anions. Supporting evidence for Mrp2 involvement in renal LY secretion
is given by Klein et al. (1997)
, showing Mrp2-like transport of LY into
plant vacuoles, and by R. Van Aubel, who used LY to inhibit
ATP-dependent transport of 17
-estradiol-17-
-D-glucuronide
in Mrp2-expressed insect cells (personal communication). The mixed
mechanism of transport was not unique for LY. A similar inhibition
pattern was found for a fluorescent mercapturic acid derivative,
MCB-cys-Nac, although some aspects of the data may be open to
interpretation because of our inability to measure cellular
accumulation of MCB-cys-Nac. Nevertheless, our result suggests that a
similar mixed mechanism of transport would be seen with other GSH
conjugates. The lack of increase in cellular fluorescence seen for both
LY and MCB-cys-Nac is consistent with earlier findings using similar
experimental conditions (Schramm et al., 1995
; Masereeuw et al., 1996
)
and indicates, most likely, that steady-state cellular levels are set
independently of events at the luminal membrane.
The teleost proximal tubule is one of the few preparations for which we
possess enough information about xenobiotic transporters and for which
we have the experimental tools needed to dissect carrier-mediated
pathways in the intact tubule. Taken together, the present data are the
first to demonstrate that xenobiotics can enter renal proximal tubule
cells on the carrier associated with one organic anion transport system
and exit into the tubular lumen on multiple carriers, one of which is
associated with a second system. This pattern of substrate crossover is
not unique to organic anions. Daunomycin, a weak organic base, enters
killifish proximal tubules both by simple diffusion and transport
mediated by the basolateral carrier for the organic cation system; it
is transported from cell to lumen by the luminal carrier for the organic cation system and by p-glycoprotein (Miller, 1995
).
Thus, a significant fraction of secreted daunomycin crosses over from the organic cation system to p-glycoprotein.
Much of current discussion of renal xenobiotic excretion is still couched in terms of transport systems for organic anions and organic cations. This is true even though it is clear that the basolateral and luminal carriers associated with a given system are not mechanistically or spatially linked but, rather, are separated by a cytoplasmic compartment. These carriers are only related through common specificity characteristics. These considerations and the mounting physiological and molecular evidence for the presence of multiple carriers with overlapping specificities in each of the membranes suggest that when we are able to follow the transport of individual substrates through the tubular epithelium, the concept of transport systems no longer will be tenable. Note that in transiting the tubular epithelium, organic anions and organic cations must cross two membrane barriers arranged in series. Because of this series arrangement, inhibition of the first step in transport not only blocks entry into the cell but may also reduce transport into the lumen (secretion). This presents a problem in interpreting previous studies of renal secretion, because transport pathways were defined primarily based on sensitivity to compounds that, at least to some extent, affected the uptake step, e.g., probenecid, PAH, and ouabain for organic anions. To better understand how chemicals are excreted in the proximal tubule, we need to identify additional agents that affect luminal transport but have only minimal effects on basolateral transport.
| |
Footnotes |
|---|
Accepted for publication December 30, 1998.
Received for publication October 2, 1998.
1 This study was supported by a grant from the Dutch Kidney Foundation (Grant C.90.1047).
Send reprint requests to: Rosalinde Masereeuw, Ph.D., Department of Pharmacology 233, Faculty of Medical Sciences, University of Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: R.Masereeuw{at}farm.kun.nl
| |
Abbreviations |
|---|
LY, lucifer yellow; LTC4, leukotriene C4; MCB, monochlorobimane; CDNB, 1-chloro-2,4-dinitrobenzene; FL, fluorescein; FL-MTX, FL-methotrexate; PAH, p-aminohippurate; Mrp2, multidrug resistance-associated protein 2; GFR, glomerular filtration rate.
| |
References |
|---|
|
|
|---|
evidence for direct energization of a sulphonated substance and implications for the design of new molecular probes.
FEBS Lett
420:
86-92[Medline].This article has been cited by other articles:
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Han, W. J. Sigurdson, P. A. Nickerson, and M. Taub Both mitogen activated protein kinase and the mammalian target of rapamycin modulate the development of functional renal proximal tubules in matrigel J. Cell Sci., May 1, 2004; 117(9): 1821 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pushkin, G. Carpenito, N. Abuladze, D. Newman, V. Tsuprun, S. Ryazantsev, S. Motemoturu, P. Sassani, N. Solovieva, R. Dukkipati, et al. Structural characterization, tissue distribution, and functional expression of murine aminoacylase III Am J Physiol Cell Physiol, April 1, 2004; 286(4): C848 - C856. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Masereeuw, S. Notenboom, P. H. E. Smeets, A. C. Wouterse, and F. G. M. Russel Impaired Renal Secretion of Substrates for the Multidrug Resistance Protein 2 in Mutant Transport-Deficient (TR-) Rats J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2741 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Breen, D. B. Sykes, G. Fricker, and D. S. Miller Confocal imaging of organic anion transport in intact rat choroid plexus Am J Physiol Renal Physiol, May 1, 2002; 282(5): F877 - F885. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. van Aubel, P. H. E. Smeets, J. G. P. Peters, R. J. M. Bindels, and F. G. M. Russel The MRP4/ABCC4 Gene Encodes a Novel Apical Organic Anion Transporter in Human Kidney Proximal Tubules: Putative Efflux Pump for Urinary cAMP and cGMP J. Am. Soc. Nephrol., March 1, 2002; 13(3): 595 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Miller Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shuprisha, S. H. Wright, and W. H. Dantzler Method for measuring luminal efflux of fluorescent organic compounds in isolated, perfused renal tubules Am J Physiol Renal Physiol, November 1, 2000; 279(5): F960 - F964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. Van Aubel, J. G. P. Peters, R. Masereeuw, C. H. Van Os, and F. G. M. Russel Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate Am J Physiol Renal Physiol, October 1, 2000; 279(4): F713 - F717. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Walgren, J.-T. Lin, R. K.-H. Kinne, and T. Walle Cellular Uptake of Dietary Flavonoid Quercetin 4'-beta -Glucoside by Sodium-Dependent Glucose Transporter SGLT1 J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 837 - 843. [Abstract] [Full Text] |
||||
![]() |
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ballatori, D. N. Hager, S. Nundy, D. S. Miller, and J. L. Boyer Carrier-mediated uptake of lucifer yellow in skate and rat hepatocytes: a fluid-phase marker revisited Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G896 - G904. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||